CAR-T Cell Therapy – Frederick Locke, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Frederick Locke, MD, Program Co-Leader, Immunology, Moffitt Cancer Center discuss CAR-T clinical highlights from ASH 2018